Dear colleagues,

I hope this will not be construed as self-promotion, but we would like to draw your attention to the following paper, we just published:

Djulbegovic B, Kumar A, Glasziou P, Miladinovic B, Chalmers I. Trial unpredictability yields predictable therapy gains. Nature 2013;500:395-396

We think the results and principles described in the paper should be a part of core EBM.

Thanks

ben